remains absent after 4 hours of infusion, check the activated partial thromboplastin time (APTT) and adjust the heparin dose appropriately to achieve a level of around 2.5 times the control value. Continue with heparin if improvement continues, otherwise go to the next step i.e. thrombolysis.
Step 2: Thrombolysis Thrombolysis should be considered if there is no clinical improvement with heparin or if the pulse fails to return despite improvement in limb perfusion after 4 hours of infusion and so long as there is no contraindication. Take baseline clotting profile (repeat APTT, prothrombin time and thrombin time) haemoglobin, fibrinogen level and cross match one unit of blood. Ensure that patient has adequate venous access. The two commonest agents used are streptokinase and recombinant tissue plasminogen activator (rTPA).
Streptokinase
Initial bolus 1000 units/kg followed by an infusion of 1000 units/kg/hr.
rTPA Regime 1
Initial bolus of 0.7 mg/kg followed by an infusion of 0.2 mg/kg/hr.
rTPA Regime 2 Infusion 0.1 to 0.5 mg/kg/hr (incremental increase of 0.1 mg/kg/hr).
End Points
1. Return of pulse. 2. Bleeding at entry site. 3. Internal bleeding e.g. haematemesis, melaena, cerebral haemorrhage, retroperitoneal bleed.
If no response after 6 hours or if clinical deterioration
If pulse becomes weaker after stopping lytic agent, start heparin infusion 10 units/Kg/Hr with the option of further increasing the dose. If pulse disappears after stopping lytic therapy, further thrombolysis can be carried out. Patients should not be discharged for 24 hours after stopping lytic agent to make sure that pulse patency persists and that there are no signs of bleeding. The risk of bleeding can be as high as 50%.
Step 3: Invasive measures If the pulse or limb perfusion fail to return despite adequate thrombolysis as assessed by thrombin time and fibrinogen levels (fibrinogen levels must be < 1.9) or if the viability of the limb is in question, consider surgery in infants or children. Adults may benefit from an intervention e.g. angioplasty or stent. Surgery often consists of thrombectomy, repair of intimal flap or repair of avulsed vessel. Heparin alone is expected to be sufficient in around 75 -80%. The rest will receive a lytic agent with complete restoration of the pulse in 65%, partial restoration in another
